H R Lijnen|D Collen - JoVE Visualize

Showing results (131-140 of 610) with videos related to

Pageof 61

Sort By:

Thrombosis and Haemostasis|December 2, 1991

Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activatorT Kurokawa, S Iwasa, A Kakinuma, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|July 22, 1998

Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genesH R Lijnen, B Van Hoef, F Lupu, et al.

Blood|May 1, 1992

Thrombolytic and pharmacokinetic properties of an immunoconjugate of single-chain urokinase-type plasminogen activator (u-PA) and a bispecific monoclonal antibody against fibrin and against u-PA in baboonsY Imura, J M Stassen, T Kurokawa, et al.

Thrombosis and Haemostasis|February 12, 1991

Thrombolytic and pharmacokinetic properties of human tissue-type plasminogen activator variants, obtained by deletion and/or duplication of structural/functional domains, in a hamster pulmonary embolism modelD Collen, H R Lijnen, I Vanlinthout, et al.

European Journal of Biochemistry|August 15, 1993

Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinaseD Collen, B Van Hoef, B Schlott, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|March 9, 2002

Matrix metalloproteinase inhibition impairs adipose tissue development in miceH R Lijnen, E Maquoi, L B Hansen, et al.

European Journal of Biochemistry|August 3, 1987

Amino-acid sequence of human alpha 2-antiplasminH R Lijnen, W E Holmes, B van Hoef, et al.

Thrombosis and Haemostasis|October 6, 1997

Characterization and targeting of the murine alpha2-antiplasmin geneK Okada, H R Lijnen, M Dewerchin, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|December 11, 1999

Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivationH R Lijnen, B Van Hoef, I Vanlinthout, et al.

Thrombosis and Haemostasis|April 2, 1992

Biochemical, thrombolytic and pharmacokinetic properties of rt-PA P47G, K49N, a substitution variant of human tissue-type plasminogen activatorL Nelles, X K Li, I Vanlinthout, et al.

Pageof 61

Showing results (131-140 of 610) with videos related to

Sort By:

Pageof 61

Thrombosis and Haemostasis|December 2, 1991

Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activatorT Kurokawa, S Iwasa, A Kakinuma, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|July 22, 1998

Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genesH R Lijnen, B Van Hoef, F Lupu, et al.

Blood|May 1, 1992

Thrombolytic and pharmacokinetic properties of an immunoconjugate of single-chain urokinase-type plasminogen activator (u-PA) and a bispecific monoclonal antibody against fibrin and against u-PA in baboonsY Imura, J M Stassen, T Kurokawa, et al.

Thrombosis and Haemostasis|February 12, 1991

Thrombolytic and pharmacokinetic properties of human tissue-type plasminogen activator variants, obtained by deletion and/or duplication of structural/functional domains, in a hamster pulmonary embolism modelD Collen, H R Lijnen, I Vanlinthout, et al.

European Journal of Biochemistry|August 15, 1993

Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinaseD Collen, B Van Hoef, B Schlott, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|March 9, 2002

Matrix metalloproteinase inhibition impairs adipose tissue development in miceH R Lijnen, E Maquoi, L B Hansen, et al.

European Journal of Biochemistry|August 3, 1987

Amino-acid sequence of human alpha 2-antiplasminH R Lijnen, W E Holmes, B van Hoef, et al.

Thrombosis and Haemostasis|October 6, 1997

Characterization and targeting of the murine alpha2-antiplasmin geneK Okada, H R Lijnen, M Dewerchin, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|December 11, 1999

Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivationH R Lijnen, B Van Hoef, I Vanlinthout, et al.

Thrombosis and Haemostasis|April 2, 1992

Biochemical, thrombolytic and pharmacokinetic properties of rt-PA P47G, K49N, a substitution variant of human tissue-type plasminogen activatorL Nelles, X K Li, I Vanlinthout, et al.

Pageof 61